NOVEMBER 2023 NEWS




Featured topic: coronavirus


On Science-Based Medicine,

David Gorski posted:


Jonathan Howard posted:


On Respectful Insolence, “Orac” posted:


Edzard Ernst posted:


November 1 – Naomi Oreskes wrote “What went wrong with a highly publicized COVID Mask analysis?” “The Cochrane Library, a trusted source of health information, misled the public by prioritizing rigor over reality.”


 

Featured topic: chiropractic

 

On Science-Based Medicine, Samuel Homola:


Edzard Ernst:

 


Featured topic: homeopathy

 

On Respectful Insolence, “Orac”:


Edzard Ernst:

 


Other topics

 

On Science-Based Medicine,

Mark Crislip:


Scott Gavura:


David Gorski:


Steven Novella:


On Respectful Insolence, “Orac”:


Edzard Ernst:


On McGill Office for Science and Society:

Jonathan Jarry:


Joe Schwarcz:


November 7 – As reported in Consumer Health Digest, “Researchers have identified 17 online direct-to-consumer advertisers of ketamine for treatment of mental health conditions…Intravenous ketamine is FDA-approved as an anesthetic but is not approved to treat any mental health problem.” The paper is Crane et al., JAMA Netw Open. 2023;6(11):e2342210 Paper.


November 13 – The FDA issued a warning letter to Amazon concerning seven eye-drop products. The products are considered unapproved new drugs. “These products are especially concerning from a public health perspective. Ophthalmic drug products, which are intended for administration into the eyes, in general pose a greater risk of harm to users because the route of administration for these products bypasses some of the body’s natural defenses.”


November 16 – The FDA issued consent decrees against a Utah-based dietary supplement distributor and manufacturer of Balance of Nature products.






PREVIOUS NEWS PAGES